Iranian Red Crescent Medical Journal

Published by: Kowsar

The Effect of Extrafascial Hysterectomy After Completion of External Beam Radiotherapy for Treatment of Locally Advanced Stages (IIB-III) of Cervical Cancer

Zahra Sarraf 1 , Bahareh Hamedi 1 , * , Soodabeh Hooshmand 1 , Ahmad Mosalaie 2 , Minoo Robati 1 , Mozhdeh Momtahan 1 and Pouya Farhadi 3
Authors Information
1 Gynecologic Oncology Ward, Department of Obstetrics and Gynecology, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Department of Radiotherapy and Oncology, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Trauma Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: December 01, 2013, 15 (12); e10758
  • Published Online: December 5, 2013
  • Article Type: Research Article
  • Received: February 18, 2013
  • Revised: April 23, 2013
  • Accepted: May 8, 2013
  • DOI: 10.5812/ircmj.10758

To Cite: Sarraf Z, Hamedi B, Hooshmand S, Mosalaie A, Robati M, et al. The Effect of Extrafascial Hysterectomy After Completion of External Beam Radiotherapy for Treatment of Locally Advanced Stages (IIB-III) of Cervical Cancer, Iran Red Crescent Med J. 2013 ; 15(12):e10758. doi: 10.5812/ircmj.10758.

Abstract
Copyright © 2013, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
Acknowledgements
Footnotes
References
  • 1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2): 69-90[DOI][PubMed]
  • 2. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 2011; 103(5): 368-83[DOI][PubMed]
  • 3. Benedetti-Panici P, Greggi S, Colombo A, Amoroso M, Smaniotto D, Giannarelli D, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol. 2002; 20(1): 179-88[PubMed]
  • 4. Eifel PJ, Berek JS, Thigpen JT. DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 2001; : 1526-56
  • 5. Stehman FB, Ali S, Keys HM, Muderspach LI, Chafe WE, Gallup DG, et al. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial. Am J Obstet Gynecol. 2007; 197(5): 503 e1-6[DOI][PubMed]
  • 6. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001; 358(9284): 781-6[DOI][PubMed]
  • 7. Neoadjuvant chemotherapy for locally advanced cervix cancer. Cochrane Database Syst Rev. 2004; (2)[DOI][PubMed]
  • 8. Kornovski Y, Ismail E, Kaneva M. [Oncological outcomes of combined therapy in patients with cervical carcinoma FIGO stage IIB]. Akush Ginekol (Sofiia). 2012; 51(4): 24-9[PubMed]
  • 9. Candelaria M, Chanona-Vilchis J, Cetina L, Flores-Estrada D, Lopez-Graniel C, Gonzalez-Enciso A, et al. Prognostic significance of pathological response after neoadjuvant chemotherapy or chemoradiation for locally advanced cervical carcinoma. Int Semin Surg Oncol. 2006; 3: 3[DOI][PubMed]
  • 10. Candelaria M, Cetina L, Garcia-Arias A, Lopez-Graniel C, de la Garza J, Robles E, et al. Radiation-sparing managements for cervical cancer: a developing countries perspective. World J Surg Oncol. 2006; 4: 77[DOI][PubMed]
  • 11. Keys HM, Bundy BN, Stehman FB, Okagaki T, Gallup DG, Burnett AF, et al. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol Oncol. 2003; 89(3): 343-53[PubMed]
  • 12. Moyses HM, Morrow CP, Muderspach LI, Roman LD, Vasilev SA, Petrovich Z, et al. Residual disease in the uterus after preoperative radiotherapy and hysterectomy in stage IB cervical carcinoma. Am J Clin Oncol. 1996; 19(5): 433-8[PubMed]
  • 13. Rouzier R, Morice P, De Crevoisier R, Pomel C, Rey A, Bonnet K, et al. Survival in cervix cancer patients treated with radiotherapy followed by radical surgery. Eur J Surg Oncol. 2005; 31(4): 424-33[DOI][PubMed]
  • 14. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, 3rd, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999; 340(15): 1154-61[DOI][PubMed]
  • 15. Resbeut M, Cowen D, Viens P, Noirclerc M, Perez T, Gouvernet J, et al. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma. Gynecol Oncol. 1994; 54(1): 68-75[DOI][PubMed]
  • 16. Houvenaeghel G, Lelievre L, Rigouard AL, Buttarelli M, Jacquemier J, Viens P, et al. Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer. Gynecol Oncol. 2006; 102(1): 74-9[DOI][PubMed]
  • 17. Classe JM, Rauch P, Rodier JF, Morice P, Stoeckle E, Lasry S, et al. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer). Gynecol Oncol. 2006; 102(3): 523-9[DOI][PubMed]
  • 18. Jurado M, Martinez-Monge R, Garcia-Foncillas J, Azinovic I, Aristu J, Lopez-Garcia G, et al. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer. Gynecol Oncol. 1999; 74(1): 30-7[DOI][PubMed]
  • 19. Mancuso S, Smaniotto D, Benedetti Panici P, Favale B, Greggi S, Manfredi R, et al. Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma. Gynecol Oncol. 2000; 78(3 Pt 1): 324-8[DOI][PubMed]
  • 20. Modarress M, Maghami FQ, Golnavaz M, Behtash N, Mousavi A, Khalili GR. Comparative study of chemoradiation and neoadjuvant chemotherapy effects before radical hysterectomy in stage IB-IIB bulky cervical cancer and with tumor diameter greater than 4 cm. Int J Gynecol Cancer. 2005; 15(3): 483-8[DOI][PubMed]
  • 21. Mariagrazia D, Anna F, Gabriella F, Francesco F, Daniela S, Giuseppe D, et al. Preoperative chemoradiotherapy in locally advanced cervical cancer: long-term outcome and complications. Gynecol Oncol. 2005; 99(3 Suppl 1)-70[DOI][PubMed]
  • 22. Cetina L, Garcia-Arias A, Candelaria M, Cantu D, Rivera L, Coronel J, et al. Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients. World J Surg Oncol. 2009; 7: 19[DOI][PubMed]
  • 23. Gershenson DM. Fertility-sparing surgery for malignancies in women. J Natl Cancer Inst Monogr. 2005; (34): 43-7[DOI][PubMed]
  • 24. Kornovski Y, Ismail E, Kaneva M. [Surgical treatment of 294 patients with invasive cervical cancer]. Akush Ginekol (Sofiia). 2012; 51(3): 25-31[PubMed]
  • 25. National Institutes of Health Consensus Development Conference statement on cervical cancer. April 1-3, 1996. Gynecol Oncol. 1997; 66(3): 351-61[PubMed]
  • 26. Duenas-Gonzalez A, Cetina L, Mariscal I, de la Garza J. Modern management of locally advanced cervical carcinoma. Cancer Treat Rev. 2003; 29(5): 389-99[PubMed]
  • 27. Macchia G, Ferrandina G, Deodato F, Ruggieri V, Massaccesi M, Salutari V, et al. Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). Gynecol Oncol. 2010; 118(2): 128-33[DOI][PubMed]
  • 28. Hockel M, Konerding MA, Heussel CP. Liposuction-assisted nerve-sparing extended radical hysterectomy: oncologic rationale, surgical anatomy, and feasibility study. Am J Obstet Gynecol. 1998; 178(5): 971-6[PubMed]
  • 29. Monk BJ, Solh S, Johnson MT, Montz FJ. Radical hysterectomy after pelvic irradiation in patients with high risk cervical cancer or uterine sarcoma: morbidity and outcome. Eur J Gynaecol Oncol. 1993; 14(6): 506-11[PubMed]
  • 30. Morice P, Haie-Meder C, Rey A, Pautier P, Lhomme C, Gerbaulet A, et al. Radiotherapy and radical surgery for treatment of patients with bulky stage IB and II cervical carcinoma. Int J Gynecol Cancer. 2000; 10(3): 239-246[PubMed]
  • 31. Houvenaeghel G, Lelievre L, Buttarelli M, Jacquemier J, Carcopino X, Viens P, et al. Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma. Eur J Surg Oncol. 2007; 33(4): 498-503[DOI][PubMed]
  • 32. Azria E, Morice P, Haie-Meder C, Thoury A, Pautier P, Lhomme C, et al. Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma. Ann Surg Oncol. 2005; 12(4): 332-7[DOI][PubMed]
  • 33. Ferrandina G, Distefano M, Ludovisi M, Morganti A, Smaniotto D, D'Agostino G, et al. Lymph node involvement in locally advanced cervical cancer patients administered preoperative chemoradiation versus chemotherapy. Ann Surg Oncol. 2007; 14(3): 1129-35[DOI][PubMed]
  • 34. Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, et al. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005; 23(30): 7428-36[DOI][PubMed]
  • 35. Levin Vic, Meghzifene Ahmed, Izewska Joanna, Tatsuzaki Hideo. Improving Cancer Care Increased Need for Radiotherapy in Developing Countries. IAEA bulletin. 2001; 43(2): 25-32
  • 36. Tatsuzaki H, Levin CV. Quantitative status of resources for radiation therapy in Asia and Pacific region. Radiother Oncol. 2001; 60(1): 81-9[PubMed]
  • 37. Zubizarreta EH, Poitevin A, Levin CV. Overview of radiotherapy resources in Latin America: a survey by the International Atomic Energy Agency (IAEA). Radiother Oncol. 2004; 73(1): 97-100[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments